Combatting Antimicrobial Resistant Bacteria

Abstract

The CARB research program focus is to establish in-house capabilities for an antibacterial drug discovery program directed toward military relevant drug-resistant bacteria that a) encompasses assessment of external products/candidates/leads that may meet DoD requirements, b) opens active intramural based discovery efforts of new potential products/candidates/leads for development, and c) fosters partnerships with external collaborators to develop/co-develop new potential antibacterial treatment therapeutics.

Document Details

Document Type
Accomplishment
Publication Date
Oct 01, 2021
Source ID
38c7d614e0862b6e9f6377d56a152180

Tags

Readers

  • Defense Technology Research and Development.
  • Infectious Disease/Epidemiology
  • Microbial Pathology

Related Documents